# A Clinical Study of Darcilil Combined With AI Combined With Pyrrotinib in the Treatment of TPBC

> **NCT06235931** · NA · RECRUITING · sponsor: **Second Affiliated Hospital of Soochow University** · enrollment: 34 (estimated)

## Conditions studied

- Breast Neoplasms

## Interventions

- **DRUG:** Darcilide +AI (letrozole/anastrozole/Exemestane) + pyrrotinib

## Key facts

- **NCT ID:** NCT06235931
- **Lead sponsor:** Second Affiliated Hospital of Soochow University
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2024-02-01
- **Primary completion:** 2025-12-01
- **Final completion:** 2026-12-01
- **Target enrollment:** 34 (ESTIMATED)
- **Last updated:** 2024-02-01


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06235931

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06235931, "A Clinical Study of Darcilil Combined With AI Combined With Pyrrotinib in the Treatment of TPBC". Retrieved via AI Analytics 2026-06-12 from https://api.ai-analytics.org/clinical/NCT06235931. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*